Exacerbated venous thromboembolism in mice carrying a protein S K196E mutation

Blood

Volumn 126, Issue 19, 2015, Pages 2247-2253

  Banno, Fumiaki ^a   Kita, Toshiyuki ^a   Fernández, José A ^b   Yanamoto, Hiroji ^a   Tashima, Yuko ^a   Kokame, Koichi ^a   Griffin, John H ^b   Miyata, Toshiyuki ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5 LEIDEN; POLYPHOSPHATE; PROTEIN S; BLOOD CLOTTING FACTOR 5; PROTEIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INFARCTION; CAUCASIAN; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; GENETIC RISK; HETEROZYGOSITY; IN VITRO STUDY; IN VIVO STUDY; INFERIOR CAVA VEIN; LUNG EMBOLISM; MIDDLE CEREBRAL ARTERY; MIDDLE CEREBRAL ARTERY ISCHEMIA REPERFUSION INJURY; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; RISK; VENOUS THROMBOEMBOLISM; WILD TYPE; AMINO ACID SUBSTITUTION; ANIMAL; BLOOD; DISEASE MODEL; GENETICS; HUMAN; METABOLISM; MISSENSE MUTATION; MUTANT MOUSE STRAIN;

AMINO ACID SUBSTITUTION; ANIMALS; DISEASE MODELS, ANIMAL; FACTOR V; HUMANS; MICE; MICE, MUTANT STRAINS; MUTATION, MISSENSE; PROTEIN C; PROTEIN S; VENOUS THROMBOEMBOLISM;

EID: 84948949781     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2015-06-653162     Document Type: Article

References (50)

1. Dahlbäck B. The tale of protein S and C4b-binding protein, a story of affection. Thromb Haemost. 2007;98(1):90-96.
2. Griffin JH, Zlokovic BV, Mosnier LO. Protein C anticoagulant and cytoprotective pathways. Int J Hematol. 2012;95(4):333-345.
3. Saller F, Brisset AC, Tchaikovski SN, et al. Generation and phenotypic analysis of protein Sdeficient mice. Blood. 2009;114(11):2307-2314.
4. García de Frutos P, Fuentes-Prior P, Hurtado B, Sala N. Molecular basis of protein S deficiency. Thromb Haemost. 2007;98(3):543-556.
5. Gómez E, Ledford MR, Pegelow CH, Reitsma PH, Bertina RM. Homozygous protein S deficiency due to a one base pair deletion that leads to a stop codon in exon III of the protein S gene. Thromb Haemost. 1994;71(6):723-726.
6. Hayashi T, Nishioka J, Shigekiyo T, Saito S, Suzuki K. Protein S Tokushima: abnormal molecule with a substitution of Glu for Lys-155 in the second epidermal growth factor-like domain of protein S. Blood. 1994;83(3):683-690.
7. Yamazaki T, Sugiura I, Matsushita T, et al. A phenotypically neutral dimorphism of protein S: the substitution of Lys155 by Glu in the second EGF domain predicted by an A to G base exchange in the gene. Thromb Res. 1993;70(5): 395-403.
8. Kinoshita S, Iida H, Inoue S, et al. Protein S and protein C gene mutations in Japanese deep vein thrombosis patients. Clin Biochem. 2005;38(10): 908-915.
9. Kimura R, Honda S, Kawasaki T, et al. Protein SK196E mutation as a genetic risk factor for deep vein thrombosis in Japanese patients. Blood. 2006;107(4):1737-1738.
10. Ikejiri M, Wada H, Sakamoto Y, et al. The association of protein S Tokushima-K196E with a risk of deep vein thrombosis. Int J Hematol. 2010;92(2):302-305.
11. Yin T, Miyata T. Dysfunction of protein C anticoagulant system, main genetic risk factor for venous thromboembolism in northeast Asians. J Thromb Thrombolysis. 2014;37(1):56-65.
12. Kimura R, Sakata T, Kokubo Y, et al. Plasma protein S activity correlates with protein S genotype but is not sensitive to identify K196E mutant carriers. J Thromb Haemost. 2006;4(9): 2010-2013.
13. Miyata T, Kimura R, Kokubo Y, Sakata T. Genetic risk factors for deep vein thrombosis among Japanese: importance of protein S K196E mutation. Int J Hematol. 2006;83(3):217-223.
14. Miyata T, Hamasaki N, Wada H, Kojima T. More on: racial differences in venous thromboembolism. J Thromb Haemost. 2012; 10(2):319-320.
15. Neki R, Fujita T, Kokame K, et al. Genetic analysis of patients with deep vein thrombosis during pregnancy and postpartum. Int J Hematol. 2011;94(2):150-155.
16. Miyata T, Sato Y, Ishikawa J, et al. Prevalence of genetic mutations in protein S, protein C and antithrombin genes in Japanese patients with deep vein thrombosis. Thromb Res. 2009;124(1): 14-18.
17. Neki R, Miyata T, Fujita T, et al. Nonsynonymous mutations in three anticoagulant genes in Japanese patients with adverse pregnancy outcomes. Thromb Res. 2014;133(5):914-918.
18. Pecheniuk NM, Elias DJ, Xu X, Griffin JH. Failure to validate association of gene polymorphisms in EPCR, PAR-1, FSAP and protein S Tokushima with venous thromboembolism among Californians of European ancestry. Thromb Haemost. 2008;99(2):453-455.
19. Liu W, Yin T, Okuda H, et al. Protein S K196E mutation, a genetic risk factor for venous thromboembolism, is limited to Japanese. Thromb Res. 2013;132(2):314-315.
20. Goldhaber SZ. Race and venous thromboembolism: nature or nurture? Circulation. 2014;129(14):1463-1465.
21. Kujovich JL. Factor V Leiden thrombophilia. Genet Med. 2011;13(1):1-16.
22. Dahlbäck B. Advances in understanding pathogenic mechanisms of thrombophilic disorders. Blood. 2008;112(1):19-27.
23. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med. 1995;332(14):912-917.
24. Cui J, Eitzman DT, Westrick RJ, et al. Spontaneous thrombosis in mice carrying the factor V Leiden mutation. Blood. 2000;96(13): 4222-4226.
25. Eitzman DT, Westrick RJ, Shen Y, et al. Homozygosity for factor V Leiden leads to enhanced thrombosis and atherosclerosis in mice. Circulation. 2005;111(14):1822-1825.
26. Kerlin BA, Yan SB, Isermann BH, et al. Survival advantage associated with heterozygous factor V Leiden mutation in patients with severe sepsis and in mouse endotoxemia. Blood. 2003;102(9): 3085-3092.
27. Wang H, Madhusudhan T, He T, et al. Low but sustained coagulation activation ameliorates glucose-induced podocyte apoptosis: protective effect of factor V Leiden in diabetic nephropathy. Blood. 2011;117(19):5231-5242.
28. Burstyn-Cohen T, Heeb MJ, Lemke G. Lack of protein S in mice causes embryonic lethal coagulopathy and vascular dysgenesis. J Clin Invest. 2009;119(10):2942-2953.
29. Okuda T, Higashi Y, Kokame K, Tanaka C, Kondoh H, Miyata T. Ndrg1-deficient mice exhibit a progressive demyelinating disorder of peripheral nerves. Mol Cell Biol. 2004;24(9):3949-3956.
30. Banno F, Kokame K, Okuda T, et al. Complete deficiency in ADAMTS13 is prothrombotic, but it alone is not sufficient to cause thrombotic thrombocytopenic purpura. Blood. 2006;107(8): 3161-3166.
31. Yamamoto H, Kokame K, Okuda T, Nakajo Y, Yanamoto H, Miyata T. NDRG4 protein-deficient mice exhibit spatial learning deficits and vulnerabilities to cerebral ischemia. J Biol Chem. 2011;286(29):26158-26165.
32. Eura Y, Yanamoto H, Arai Y, Okuda T, Miyata T, Kokame K. Derlin-1 deficiency is embryonic lethal, Derlin-3 deficiency appears normal, and Herp deficiency is intolerant to glucose load and ischemia in mice. PLoS One. 2012;7(3):e34298.
33. Fernández JA, Heeb MJ, Xu X, Singh I, Zlokovic BV, Griffin JH. Species-specific anticoagulant and mitogenic activities of murine protein S. Haematologica. 2009;94(12):1721-1731.
34. Diaz JA, Alvarado CM, Wrobleski SK, et al. The electrolytic inferior vena cava model (EIM) to study thrombogenesis and thrombus resolution with continuous blood flow in the mouse. Thromb Haemost. 2013;109(6):1158-1169.
35. Tashima Y, Banno F, Akiyama M, Miyata T. Influence of ADAMTS13 deficiency on venous thrombosis in mice. Thromb Haemost. 2015; 114(1):206-207.
36. Smith SA, Choi SH, Davis-Harrison R, et al. Polyphosphate exerts differential effects on blood clotting, depending on polymer size. Blood. 2010; 116(20):4353-4359.
37. Müller F, Mutch NJ, Schenk WA, et al. Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo. Cell. 2009;139(6): 1143-1156.
38. Yanamoto H, Nagata I, Niitsu Y, Xue JH, Zhang Z, Kikuchi H. Evaluation of MCAO stroke models in normotensive rats: standardized neocortical infarction by the 3VO technique. Exp Neurol. 2003;182(2):261-274.
39. Yang D, Nakajo Y, Iihara K, et al. An integrated stroke model with a consistent penumbra for the assessment of neuroprotective interventions. Eur Neurol. 2014;71(1-2):4-18.
40. Wojcik BM, Wrobleski SK, Hawley AE, Wakefield TW, Myers DD Jr, Diaz JA. Interleukin-6: a potential target for post-thrombotic syndrome. Ann Vasc Surg. 2011;25(2):229-239.
41. DeRoo EP, Wrobleski SK, Shea EM, et al. The role of galectin-3 and galectin-3-binding protein in venous thrombosis. Blood. 2015;125(11): 1813-1821.
42. Kita T, Banno F, Yanamoto H, Nakajo Y, Iihara K, Miyata T. Large infarct and high mortality by cerebral ischemia in mice carrying the factor V Leiden mutation. J Thromb Haemost. 2012;10(7): 1453-1455.
43. MacArthur DG, Manolio TA, Dimmock DP, et al. Guidelines for investigating causality of sequence variants in human disease. Nature. 2014; 508(7497):469-476.
44. Rodríguez de Córdoba S, Pérez-Blas M, Ramos-Ruiz R, Sánchez-Corral P, Pardo-Manuel de Villena F, Rey-Campos J. The gene coding for the beta-chain of C4b-binding protein (C4BPB) has become a pseudogene in the mouse. Genomics. 1994;21(3):501-509.
45. Maruyama K, Akiyama M, Kokame K, Sekiya A, Morishita E, Miyata T. ELISA-based detection system for protein S K196E mutation, a genetic risk factor for venous thromboembolism. PLoS One. 2015;10(7):e0133196.
46. Liu S, Zhen G, Meloni BP, Campbell K, Winn HR. Rodent stroke model guidelines for preclinical stroke trials (1st edition). J Exp Stroke Transl Med. 2009;2(2):2-27.
47. Zhu D, Wang Y, Singh I, et al. Protein S controls hypoxic/ischemic blood-brain barrier disruption through the TAM receptor Tyro3 and sphingosine 1-phosphate receptor. Blood. 2010;115(23): 4963-4972.
48. Zhong Z, Wang Y, Guo H, et al. Protein S protects neurons from excitotoxic injury by activating the TAM receptor Tyro3-phosphatidylinositol 3-kinase-Akt pathway through its sex hormonebinding globulin-like region. J Neurosci. 2010; 30(46):15521-15534.
49. Griffin JH, Zlokovic BV, Mosnier LO. Activated protein C: biased for translation. Blood. 2015; 125(19):2898-2907.
50. Abrams ET, Rutherford JN. Framing postpartum hemorrhage as a consequence of human placental biology: an evolutionary and comparative perspective. Am Anthropol. 2011; 113(3):417-430.